Skip to main content
. 2022 Feb 6;14(3):826. doi: 10.3390/cancers14030826

Figure 1.

Figure 1

Overall survival in all patients (Panel (A)), in selected AML type subgroups (Panel (B)), and karyotype profile (Panel (C)). Italy, 2013–2021.